Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Q102140349)
Jump to navigation
Jump to search
scientific article published on 17 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial |
scientific article published on 17 November 2020 |
Statements
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (English)
Christina M Eckhardt
Matthew J Cummings
Kartik N Rajagopalan
Sarah Borden
Zachary C Bitan
Allison Wolf
Alex Kantor
Thomas Briese
Benjamin J Meyer
Samuel D Jacobson
Dawn Scotto
Nischay Mishra
Neena M Philip
Brie A Stotler
Joseph Schwartz
Beth Shaz
Steven L Spitalnik
Andrew Eisenberger
Eldad A Hod Jessica Justman
Ken Cheung
W Ian Lipkin
Max R O'Donnell
17 November 2020